Steamboat Capital Partners’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Steamboat Capital Partners's BMY Position: Q4 2020 in Review
Steamboat Capital Partners sold out of Bristol-Myers Squibb (BMY) in Q4 2020, closing a stake of 102,365 shares — an estimated $6.17M sold.
Steamboat Capital Partners first reported a position in BMY in Q4 2019 and held it in 4 quarters. The position peaked at $7.7M in Q4 2019. 2,359 funds tracked by Wall St. Rank hold BMY as of Q4 2020.
- Steamboat Capital Partners reported no remaining Bristol-Myers Squibb position as of Q4 2020 after selling out during the quarter.
- Steamboat Capital Partners sold 102,365 Bristol-Myers Squibb shares in Q4 2020, an estimated $6.17M.
- Steamboat Capital Partners first reported a position in Bristol-Myers Squibb in Q4 2019 and held it in 4 quarters.
- Steamboat Capital Partners's Bristol-Myers Squibb position peaked at $7.7M in Q4 2019.
- 2,359 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2020.
Based on Steamboat Capital Partners's 13F filing for Q4 2020, filed 16 Feb 2021.